• Hematologic Malignancy Center

    Dr. Lewis Silverman with Patient 

    The Hematologic Malignancy Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top centers of it's kind in the world. In addition to treating lymphomas and leukemias, we treat the primary types of histiocytosis, which is not a form of cancer but shares some common characteristics and is often treated using some of the same therapies.

    Highlights of the Hematologic Malignancy Center include:

    • Internationally recognized doctors who are considered leaders in their field
    • Expert hematopathologic evaluation
    • Specialized programs for the treatment of leukemialymphomahistiocytosis and lymphadenopathy 
    • Advanced diagnostic techniques, including flow cytometry and molecular testing to screen for specific chromosomal abnormalities
    • Specialized methods to detect minimal residual disease (levels of disease that cannot be seen under a microscope)
    • Innovative treatment options, including experimental therapies for relapsed, recurrent or refractory leukemia and lymphoma
    • Access to an internationally recognized pediatric Stem Cell Transplant Center 
    Dr. Lynda Vrooman Young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy, suggest the findings of a clinical trial led by investigators at Dana-Farber/Boston Children's.
    • fertility preservation small

      Fertility Preservation

      A specialized program for patients receiving cancer treatment who have experienced a decrease or loss of reproductive function.

    • survivor small

      Survivorship Services

      Providing care and advocacy for survivors of childhood cancer through ongoing education, support and research on the long-term effects of cancer treatments.

    • psychosocial oncology

      Psychosocial Services

      Social workers, psychologists and resource specialists offering help with the social, emotional, and psychological aspects of caring for children with cancer.

  • Contact Us

    Call 1-855-320-2092 for questions about treatment, second opinions, and new patient scheduling.
  • Hematologic Malignancy Clinical Trials

    Search our wide range of clinical trials for hematologic malignancies, including lymphoma, leukemia and histiocytosis. callout bg
  • Sarah Levin's Story

    Sarah Levine Leukemia Story 

    Sarah Levin is 11 years old, and has beaten acute lymphoblastic leukemia (ALL) twice. This is her story in her own words on the Boston Children's Hospital Blog Thriving.

  • Our Affiliations

    HMS Callout FAD 

    Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.